1. Home
  2. WAY vs GKOS Comparison

WAY vs GKOS Comparison

Compare WAY & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAY
  • GKOS
  • Stock Information
  • Founded
  • WAY 1999
  • GKOS 1998
  • Country
  • WAY United States
  • GKOS United States
  • Employees
  • WAY N/A
  • GKOS N/A
  • Industry
  • WAY
  • GKOS Medical/Dental Instruments
  • Sector
  • WAY
  • GKOS Health Care
  • Exchange
  • WAY Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • WAY 6.7B
  • GKOS 5.8B
  • IPO Year
  • WAY 2024
  • GKOS 2015
  • Fundamental
  • Price
  • WAY $37.77
  • GKOS $103.82
  • Analyst Decision
  • WAY Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • WAY 13
  • GKOS 13
  • Target Price
  • WAY $42.23
  • GKOS $135.15
  • AVG Volume (30 Days)
  • WAY 1.6M
  • GKOS 845.8K
  • Earning Date
  • WAY 07-30-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • WAY N/A
  • GKOS N/A
  • EPS Growth
  • WAY N/A
  • GKOS N/A
  • EPS
  • WAY 0.15
  • GKOS N/A
  • Revenue
  • WAY $975,192,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • WAY $8.95
  • GKOS $27.88
  • Revenue Next Year
  • WAY $9.44
  • GKOS $27.60
  • P/E Ratio
  • WAY $244.08
  • GKOS N/A
  • Revenue Growth
  • WAY 18.25
  • GKOS 23.92
  • 52 Week Low
  • WAY $20.74
  • GKOS $77.10
  • 52 Week High
  • WAY $48.11
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • WAY N/A
  • GKOS 57.69
  • Support Level
  • WAY N/A
  • GKOS $101.30
  • Resistance Level
  • WAY N/A
  • GKOS $106.82
  • Average True Range (ATR)
  • WAY 0.00
  • GKOS 3.17
  • MACD
  • WAY 0.00
  • GKOS 0.19
  • Stochastic Oscillator
  • WAY 0.00
  • GKOS 72.45

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: